TrialAnnals of surgical oncology2015

Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.

Christina L Roland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.